National
April 29, 2021
SUKKUR: A discussion was held for medical professionals regarding Covid-19 treatment through Ivermectin in the early stages and IV Methylprednisolone.
The discussion was held on platform of The Impact, a non-profit organization, to facilitate and help capacity building of Pakistani healthcare professionals. Wednesday’s discussion revolved around the treatment of Covid-19 to assist the front line doctors engaged in battling the third wave of the contagion.
The keynote speaker was Professor Paul E Marik, Professor of Medicine and Chief of the Pulmonary and Critical Care Medicine Division at Eastern Virginia Medical School in Norfolk, Virginia. Marik advocated using Ivermectin in the early stages, and IV Methylprednisolone in the later “pulmonary phase” of the disease. He went on to say that these medicines were efficacious, safe, inexpensive and widely available. If used in the early stages of the disease, the drugs have proved to cause statistically
Opinion: A peek behind the curtain reveals flawed pricing model for health care pilotonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pilotonline.com Daily Mail and Mail on Sunday newspapers.
“I salute the medical staff & frontline workers for their tireless service”: Seema Singh, founder, Meghashrey
SPOTLIGHT / Updated: Apr 27, 2021, 21:10 IST
Meghashrey Logo
Seema Singh, the founder of Meghashrey, thanked all the Doctors who are the true heroes and are working like true warriors. “It is the most terrible time we all are going through due to this pandemic, but it takes immense courage to be out there at service for all the people suffering from the current pandemic”, she said.
Below are some of the people from the field of healthcare who have worked tirelessly in this period to serve the society:
Dr Simko recognized by EVMS – Gazette Journal gazettejournal.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gazettejournal.net Daily Mail and Mail on Sunday newspapers.